Related Experiment Video
Updated: Apr 28, 2026

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
Published on: March 26, 2015
Tissue remodeling in periplaque regions of multiple sclerosis spinal cord lesions
Alice Lieury1, Marie Chanal, Géraldine Androdias
1INSERM U1028, CNRS UMR 5292, Lyon Neuroscience Research Center, Neuro-Oncology and Neuro-Inflammation Team, Lyon, France; University Lyon 1, Lyon, France.
Abstract:
Our knowledge of multiple sclerosis (MS) neuropathology has benefited from a number of studies that provided an in-depth description of plaques and, more recently, diffuse alterations of the normal-appearing white or grey matter. However, there have been few studies focusing on the periplaque regions surrounding demyelinated plaques, notably in MS spinal cords. In this context, the present study aimed to analyze the molecular immunopathology of periplaque demyelinated lesions (PDLs) in the spinal cord of patients with a progressive form of MS. To achieve this goal, the neuropathological features of PDLs were analyzed in postmortem tissues derived from the cervical spinal cord of 21 patients with primary or secondary progressive MS. We found that PDLs covered unexpectedly large areas of incomplete demyelination and were characterized by the superimposition of pro- and anti-inflammatory molecular signatures. Accordingly, macrophages/microglia accumulated in PDLs but exhibited a poor phagocytic activity toward myelin debris. Interestingly, while genes of the oligodendrocyte lineage were consistently down-regulated in PDLs, astrocyte-related molecules such as aquaporin 4, connexin 43 and the glutamate transporter EAAT1, were significantly upregulated in PDLs at the mRNA and protein levels. Overall, our work indicates that in the spinal cord of patients with a progressive form of MS, a tissue remodeling process that is temporally remote from plaque development takes place in PDLs. We propose that in spinal cord PDLs, this process is supported by subtle alterations of astrocyte functions and by low-grade inflammatory events that drive a slowly progressive loss of myelin and a failure of remyelination.
Insights
Periplaque regions in progressive multiple sclerosis (MS) spinal cords show incomplete demyelination and altered astrocyte function. These findings suggest a slow myelin loss and failed remyelination process in these MS lesions.
Area of Science:
- Neuroscience
- Immunopathology
- Neuropathology
Background:
- Multiple sclerosis (MS) neuropathology research has focused on plaques and diffuse white/grey matter changes.
- Limited studies have investigated periplaque regions, especially in MS spinal cords.
Purpose of the Study:
- To analyze the molecular immunopathology of periplaque demyelinated lesions (PDLs) in the spinal cord of progressive MS patients.
- To understand the neuropathological features and molecular signatures within these specific MS lesions.
Main Methods:
- Analysis of postmortem cervical spinal cord tissues from 21 patients with progressive MS.
- Investigated neuropathological features of PDLs, including cellular infiltration and molecular markers.
Main Results:
- PDLs exhibited extensive incomplete demyelination with mixed pro- and anti-inflammatory signatures.
- Macrophages/microglia showed poor myelin debris phagocytosis.
- Oligodendrocyte lineage genes were downregulated, while astrocyte molecules (AQP4, Cx43, EAAT1) were upregulated at mRNA and protein levels.
Conclusions:
- Spinal cord PDLs in progressive MS undergo tissue remodeling distinct from plaque development.
- Subtle astrocyte alterations and low-grade inflammation in PDLs contribute to progressive myelin loss and impaired remyelination.
Related Concept Videos
Secondary Spinal Cord Injury llI: Pathophysiology
Neurogenesis and Regeneration of Nervous Tissue
Multiple Sclerosis l: Introduction
Spinal Cord Injury ll: Pathophysiology

